Summary of HR 5158 - Fair Price Device Act

Overview

The Fair Price Device Act (HR 5158) was introduced in the House of Representatives on September 4, 2025. The primary sponsor of the bill is Hillary J. Scholten. The bill aims to address pricing transparency and fairness in the medical device market.

Purpose and Intent

The main purpose of the Fair Price Device Act is to ensure that consumers, healthcare providers, and insurers have access to clear and fair pricing information for medical devices. The bill seeks to prevent price gouging and promote competition among manufacturers, ultimately leading to lower costs for patients and healthcare systems.

Key Provisions

The Fair Price Device Act includes several significant provisions:

• Pricing Transparency: Manufacturers of medical devices will be required to disclose the prices of their products to healthcare providers and patients before a purchase is made.

• Price Regulation: The bill proposes the establishment of a regulatory framework to monitor and regulate the pricing of medical devices, ensuring that prices are fair and justified based on production costs and market conditions.

• Reporting Requirements: Medical device manufacturers will be mandated to report their pricing structures and any changes to the prices of their devices to a designated federal agency.

• Consumer Protections: The bill includes provisions to protect consumers from unexpected price increases and to provide them with recourse if they believe they have been charged unfairly.

Affected Parties

The Fair Price Device Act would impact several stakeholders in the healthcare system, including:

• Patients: Individuals seeking medical devices will benefit from increased transparency and potentially lower prices.

• Healthcare Providers: Hospitals and clinics will have clearer pricing information, allowing them to make more informed purchasing decisions.

• Medical Device Manufacturers: Companies will need to adapt to new reporting and pricing transparency requirements, which may affect their pricing strategies.

• Insurers: Insurance companies will have better data to negotiate prices and coverage options for medical devices.

Legislative Process

As of now, HR 5158 has been referred to the House Committee on Energy and Commerce for further consideration. The bill is currently in the introductory stage, and additional legislative actions will determine its progress through Congress.

Conclusion

The Fair Price Device Act represents a significant step towards enhancing pricing transparency and fairness in the medical device industry. By requiring manufacturers to disclose prices and regulating pricing practices, the bill aims to protect consumers and promote a more competitive market. Stakeholders will need to stay informed as the bill moves through the legislative process.